Skip to content
NEW: CREATE AN AI-ASSISTED TENDER IN 2 MINUTES — TRY IT FREE
Back to search
80 Beats Medical – Fertigung

Develops non-invasive cardiovascular diagnostics (VICORDER®) and ML-based clinical decision support.

80 Beats Medical Logo

80 Beats Medical GmbH

BerlinNew on Amplifa

2023Rebranding from SMT Medical Technology to 80 Beats Medical,
1,000+VICORDER® devices in use worldwide
60+innovative measurement parameters and digital biomarkers
245+VICORDER installations (according to website)

About 80 Beats Medical

80 Beats Medical GmbH is a medical technology company based in Berlin (Kantstraße 105), spun off from SMT Medical Technology in 2023. The company develops non-invasive solutions for assessing cardiovascular risk and operates the resulting diagnostic and screening applications. Its core product is the VICORDER® platform with more than 60 measurement parameters and digital biomarkers such as pulse wave analysis, central blood pressure, pulse wave velocity and ankle-brachial index; more than 1,000 devices are in use worldwide. Fields of application include Women's Health (including risk assessment of hypertensive pregnancy disorders), screening and preventive health, as well as research and clinical studies. The company is currently developing an ML-based clinical decision support system for preeclampsia and gestational hypertension, funded through Berlin ProFIT/EFRE. Registrations exist in the USA, Europe and China; distribution is partly handled through partners such as MedTach in Canada.

Site
Berlin
Processes
Development of non-invasive cardiovascular diagnostics (VICORDER®), Health Screening, Risk stratification using digital biomarkers and machine learning, Clinical decision support, Distribution in selected markets via sales partners
Materials
VICORDER® Platform, ML-based clinical decision support
Industries
Medical Technology / Cardiovascular Diagnostics, Women's Health, Preventive Healthcare / Screening, Clinical Research
  1. 01

    Research and development (hardware, sensors, software/ML)

  2. 02

    Regulatory registration (USA, Europe, China)

  3. 03

    Distribution via direct business and sales partners

  4. 04

    Support for research and clinical application

Products and Technologies

VICORDER

VICORDER® Platform

Non-invasive diagnostic system for cardiovascular biomarkers using simple cuffs and sensors.

ML-CDS

ML-based clinical decision support

Combines cardiovascular measurements with patient data into a clinically interpretable risk score.

Site

Berlin

DE

Headquarters

Diagnostic Parameters

VICORDER®
VICORDER®Non-invasive diagnostics · Cardiovascular medical technology

Inside the production

Diagnostics
Diagnostics
Preventive Health
Preventive Health
Research and Clinical Studies
Research and Clinical Studies
EU-funded project: ML-based risk assessment of hypertensive
EU-funded project: ML-based risk assessment of hypertensive

Industries

Medical Technology / Cardiovascular DiagnosticsWomen's HealthPreventive Healthcare / ScreeningClinical Research

Additional services

Development of non-invasive cardiovascular diagnostics (VICORDER®)Health ScreeningRisk stratification using digital biomarkers and machine learningClinical decision supportDistribution in selected markets via sales partners

History

  1. 2023

    SMT Medical Technology rebrands to 80 Beats Medical; new headquarters in Berlin (announcement dated April 3, 2023).

  2. 2024

    Participation in ARTERY 2024, exclusive data-sharing agreement with King's College London, MedTach as sales partner for VICORDER® in Canada.

  3. 2026

    Selection for the Springboard Women's Health Accelerator; EU co-financing (Berlin ProFIT/EFRE) of an ML-based risk assessment system for hypertensive pregnancy disorders.

Personalised demo

Ready to see Amplifa Marketplace in action?

From a structured request to the right manufacturing partner: AI-assisted matching, verified suppliers and transparent metrics — in one place for industrial companies across the DACH region.

Request a demo